Kezar Life Sciences, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 05/15/2025 | 720.00 K | $3.51 M | 0.00% | 9.86% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 05/15/2025 | 716.76 K | $3.50 M | 0.00% | 9.81% |
AVIDITY PARTNERS MANAGEMENT LP | 05/15/2025 | 502.60 K | $2.45 M | 0.00% | 6.88% |
BML CAPITAL MANAGEMENT, LLC | 05/07/2025 | 408.14 K | $1.99 M | 738.62% | 5.59% |
VANGUARD GROUP INC | 05/09/2025 | 276.23 K | $1.35 M | 0.77% | 3.78% |
ORBIMED ADVISORS LLC | 05/15/2025 | 192.70 K | $940.38 K | 0.00% | 2.64% |
ADAR1 CAPITAL MANAGEMENT, LLC | 05/15/2025 | 147.40 K | $719.33 K | 0.00% | 2.02% |
ACADIAN ASSET MANAGEMENT LLC | 05/21/2025 | 133.53 K | $650.00 K | -8.33% | 1.83% |
04/30/2025 | 124.43 K | $607.20 K | 0.35% | 1.70% | |
SPHERA FUNDS MANAGEMENT LTD. | 05/15/2025 | 108.47 K | $529.35 K | 0.00% | 1.48% |
IKARIAN CAPITAL, LLC | 05/15/2025 | 106.90 K | $521.68 K | 0.00% | 1.46% |
STONEPINE CAPITAL MANAGEMENT, LLC | 05/14/2025 | 100.00 K | $488.00 K | -9.09% | 1.37% |
RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 85.58 K | $417.65 K | -2.40% | 1.17% |
QIMING U.S. VENTURES MANAGEMENT, LLC | 05/15/2025 | 82.87 K | $404.41 K | 0.00% | 1.14% |
BLACKROCK, INC. | 05/02/2025 | 82.61 K | $403.16 K | -0.29% | 1.13% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 67.56 K | $329.79 K | 1.49% | 0.92% |
SHAY CAPITAL LLC | 05/15/2025 | 67.51 K | $329.45 K | 14.12% | 0.92% |
TWO SIGMA ADVISERS, LP | 05/15/2025 | 64.51 K | $314.80 K | -35.58% | 0.88% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2025 | 41.00 K | $200.08 K | 100.00% | 0.56% |
DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 32.31 K | $157.67 K | 0.00% | 0.44% |
TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 31.87 K | $155.53 K | -48.58% | 0.44% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 31.38 K | $153.13 K | -27.59% | 0.43% |
RBF CAPITAL, LLC | 05/15/2025 | 28.25 K | $137.88 K | 0.00% | 0.39% |
GOLDMAN SACHS GROUP INC | 06/27/2025 | 28.18 K | $137.51 K | -46.09% | 0.39% |
WOODLINE PARTNERS LP | 05/15/2025 | 25.56 K | $124.71 K | 100.00% | 0.35% |
STATE STREET CORP | 05/15/2025 | 21.09 K | $102.93 K | 0.00% | 0.29% |
BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2025 | 20.90 K | $101.99 K | 0.00% | 0.29% |
SQUAREPOINT OPS LLC | 05/15/2025 | 20.30 K | $99.06 K | 100.00% | 0.28% |
CLEAR HARBOR ASSET MANAGEMENT, LLC | 05/15/2025 | 15.81 K | $77.13 K | 100.00% | 0.22% |
FMR LLC | 05/12/2025 | 14.31 K | $69.81 K | 70.28% | 0.20% |
NORTHERN TRUST CORP | 05/13/2025 | 13.94 K | $68.03 K | 0.00% | 0.19% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 11.80 K | $57.58 K | -3.28% | 0.16% |
MORGAN STANLEY | 05/15/2025 | 7.21 K | $35.19 K | -65.01% | 0.10% |
WELLS FARGO & COMPANY/MN | 05/13/2025 | 5.70 K | $27.83 K | -7.67% | 0.08% |
UBS GROUP AG | 05/13/2025 | 2.04 K | $9.96 K | -86.25% | 0.03% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 172 | $839 | 1.18% | 0.00% |
JPMORGAN CHASE & CO | 05/12/2025 | 166 | $810 | -98.60% | 0.00% |
CIBC PRIVATE WEALTH GROUP, LLC | 05/14/2025 | 100 | $402 | 100.00% | 0.00% |
BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 96 | $468 | -11.93% | 0.00% |
CITIGROUP INC | 05/12/2025 | 51 | $249 | 0.00% | 0.00% |
ADVISOR GROUP HOLDINGS, INC. | 05/12/2025 | 4 | $20 | -99.15% | 0.00% |
AMUNDI | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
MARQUETTE ASSET MANAGEMENT, LLC | 04/09/2025 | 0 | $0 | -100.00% | 0.00% |
CITADEL ADVISORS LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
SIMPLEX TRADING, LLC | 05/12/2025 | 0 | $0 | -100.00% | 0.00% |
TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
ADVISOR GROUP HOLDINGS, INC. | 05/12/2025 | 0 | $0 | -100.00% | 0.00% |
AFFINITY ASSET ADVISORS, LLC | 05/14/2025 | 0 | $0 | -100.00% | 0.00% |
Kezar Life Sciences, Inc. institutional Ownership - FAQ's
During the previous two years, 61 institutional investors and hedge funds held shares of Kezar Life Sciences, Inc.. The most heavily invested institutionals were:
TANG CAPITAL MANAGEMENT LLC: 720,000
SUVRETTA CAPITAL MANAGEMENT, LLC: 716,759
Avidity Partners Management LP: 502,600
BML Capital Management, LLC: 408,138
VANGUARD GROUP INC: 276,228
ORBIMED ADVISORS LLC: 192,700
59.25% of Kezar Life Sciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 7.52 M shares in the last 24 months. This purchase volume represents approximately $34.43 M in transactions.